View on market: Volatility Prevails, Market is searching for better value
Early on Monday, the Asia-Pacific share indices increased in line with Wall Street as traders’ appetite for risk increased due to the likelihood that the May U.S. inflation report would be less than anticipated. As of 06:33 a.m., the Nikkei 225 was up 56.58 points, or 0.15%, at 38,702.69, while the S&P ASX 200 was up 48.70 points, or 0.63%, at 7,776.30. As of Friday, the Nasdaq Composite and S&P 500 Index both increased by 1.10% and 0.70%, respectively. 0.01% was added to the Dow Jones Industrial Average. Due to Memorial Day, markets in the US and the UK will be closed on Monday. At $82.22 per barrel, Brent crude was up 0.10 percent on the market. An ounce of gold was trading at $2,335.38, up 0.07%.
Economic Calendar:
- USD : Durable Goods Orders (MoM) (Apr) on 24th May, 2024
- USD : CB Consumer Confidence (May) on 28th May, 2024
- INR : FX Reserves, USD on 24th May, 2024
- INR : Bank Loan Growth on 31st May, 2024
Brokerage Radar:
JEFFERIES ON HINDALCO: Buy, TP raised to Rs 810; Novelis’ 4Q EBITDA rose 28% YoY(+13% QoQ) & inline; Vol grew 2% YoY while EBITDA/t rose 8% QoQ to $540, Raise FY25-26E EPS by 2-3%; Vals reasonable at 6.1x FY25E EV/EBITDA
CITI ON MARICO: Buy, TP raised to Rs 610; 4Q In-line; Pricing Action to Drive Growth Expect trajectory to improve in FY25E:
a)vol growth acceleration
b)pricing-led growth
NOMURA ON LUPIN: Buy, TP Rs 1949; 4Q: EBITDA 8% higher than est. Co expects stronger FY25 (vs FY24) driven by growth across key geographies & improvement in EBITDA margins; Think US product launches & a tight leash on costs could present upside potential to current earnings est.
International Markets:
U.S & Europe:
Particulars | 24th May | Chg. | Chg.(%) |
Nasdaq | 16920.79 | 184.76 | 1.10 |
Dow | 39069.59 | 4.33 | 0.01 |
FTSE | 8317.59 | -21.64 | -0.26 |
CAC | 8094.97 | -7.36 | -0.09 |
DAX | 18693.37 | 2.05 | 0.01 |
Dow Fut.* | 39021.10 | -48.49 | -0.12 |
Asian markets:
Particulars | 27th May | Chg. | Chg.(%) |
GIFT Nifty | 3060.00 | 20.50 | 0.09 |
Nikkei | 38758.96 | 112.85 | 0.29 |
Straits Times | 3320.01 | 3.45 | 0.10 |
Hang Seng | 18659.29 | 50.35 | 0.27 |
Shanghai | 3097.41 | 8.54 | 0.28 |
ADR Watch:
Particulars | 24th May | Chg. | Chg.(%) |
Dr. Reddy | 69.53 | -0.09 | -0.12 |
HDFC Bank | 58.00 | 1.23 | 2.17 |
ICICI Bank | 27.32 | 0.23 | 0.85 |
Infosys | 17.36 | -0.04 | -0.23 |
Wipro | 5.45 | -0.01 | -0.18 |
Commodities & Currency:
Particulars | Current Price | Chg.(%) |
USD/INR | 83.08 | 0.03% |
Brent | 82.13 | 0.35% |
Gold | 2370.85 | 1.56% |
Silver | 31.05 | 1.81% |
FIIs & DIIs:
Particulars | 24th May | 23rd May |
FIIs | -944.83 | 4670.95 |
DIIs | 2320.32 | 146.51 |
News Update:
Indian Oil Corporation: The company acquired a 100% stake in Mercator Petroleum for Rs 154 crore.
TVS Motor Company: The company announced the launch of the TVS HLX 125 with 5-gears in Tanzania.
NTPC: The company’s Q4 coal plant PLF was at 79.77% vs. 80.32% YoY, Q4 commercial generation was at 92.967 BU vs. 89.445 BU YoY and Q4 captive mine coal output at 7.87 MT vs 6.48 MT YoY. The company gave in-principle approval for incorporation of a wholly owned subsidiary company for undertaking Nuclear Energy Business, subject to the approval of its administrative Ministry.
Godrej Properties: The company clarified on the reports on the Mumbai project that it has not received communication from any concerned authority citing non-compliance.
Tata Steel: The NCLT of Kolkata Bench approved the scheme of amalgamation with Indian Steel & Wire Products The approval is pending from the Mumbai NCLT bench.
RVNL: The company emerged as the lowest bidder for the construction project worth Rs 187 crore from MMRCL.
Vodafone Idea: The deal to sell Firefly Networks’ stake to Manipura Digital Infrastructure is terminated due to non-fulfillment of certain conditions.
Bosch: The company approved the sale of OE/OES diagnosis business from Mobility Aftermarket to ETAS Automotive for Rs 45.6 crore.
Macrotech Developers: The company acquired the remaining 50% stake of Siddhivinayak Realties arm for Rs 415.6 crore.
Dr Reddy’s: The company’s Russia-based arm in a pact with Novartis Pharma to sell anti-diabetes products in Russia.
Sparc: The board approved raising Rs 1,800 crore and accepted the resignation of CFO Chetan Rajpara effective June 5 and appointed Anup Rathi as CFO effective June 6.
Source: Moneycontrol, Bloomberg Quint, Investing
Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014
Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Kiran Tahlani, Elite Wealth Limited, kirantahlani@elitestock.com
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or e-mailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone: 011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
- Reports
- a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
- Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the subject company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL
Provided that research analyst or research entity shall not be required to make a disclosure as per sub-clauses (c), (d) and (e) of clause (ii) or sub-clauses (a) and (b) of clause (iii) to the extent such disclosure would reveal material non-public information regarding specific potential future investment banking or merchant banking or brokerage services transactions of the subject company.
(4) EWL or its proprietor has never served as an officer, director or employee of the subject company;
(5) EWL has never been engaged in market making activity for the subject company;
(6) EWL shall provide all other disclosures in research report and public appearance as specified by the Board under any other regulations.